SGLT2 Inhibitors Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Clinical Trials
• Forums

SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients With Acute Myocardial Infarction, a Prospective, Multi-center Registry Study
Conditions:   Myocardial Infarction;   Diabetes Mellitus, Type 2 Intervention:   Drug: SGLT2 inhibitor Sponsors:   Kiyuk Chang;   Seoul St. Mary's Hospital;   Uijeongbu St. Mary Hospital;   Incheon St.Mary's Hospital;   Daejeon St. Mary's hospital;   Bucheon St. Mary's Hospital;   St Vincent's Hospital;   Yeouido St. Mary's Hospital;   Sejong General Hospital;   Pusan National  University Hospital;   Andong Hospital;   Chungnam National University Hospital;   St. Carollo General Hospital;   Pusan National University Yangsan Hospital;   Kyungpook National Univers...
Source: ClinicalTrials.gov - March 15, 2023 Category: Research Source Type: clinical trials

Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2) in Major Depressive Disorder (MDD)
Condition:   Major Depressive Disorder Intervention:   Drug: Empagliflozin Sponsors:   NYU Langone Health;   American Society of Clinical Psychopharmacology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2023 Category: Research Source Type: clinical trials